第 1 到 15 筆結果,共 15 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2022 | Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross-sectional survey and meta-analysis | MEI-JYH CHEN ; Bair, Ming-Jong; Chen, Po-Yueh; Lee, Ji-Yuh; Yang, Tsung-Hua; YU-JEN FANG ; CHIEH-CHANG CHEN ; Chang, An-Ti; Hsiao, Wang-De; Yu, Jian-Jyun; Kuo, Chia-Chi; Chiu, Min-Chin; Kun-Pei Lin ; Tsai, Min-Horn; Hsu, Yao-Chun; Chou, Chu-Kuang; Chen, Chi-Yi; JAW-TOWN LIN ; YI-CHIA LEE ; MING-SHIANG WU ; JYH-MING LIOU ; forthe Taiwan Gastrointestinal Disease; Helicobacter Consortium | Helicobacter | 7 | 6 | |
2 | 2021 | Bismuth salts with versus without acid suppression for Helicobacter pylori infection: A transmission electron microscope study | TSUNG-HSIEN CHIANG ; CHIEH-CHANG CHEN ; PING-HUEI TSENG ; JYH-MING LIOU ; MING-SHIANG WU ; CHIA-TUNG SHUN ; YI-CHIA LEE ; Graham, David Y | Helicobacter | 8 | 7 | |
3 | 2021 | The interplay between Helicobacter pylori and gastrointestinal microbiota | CHIEH-CHANG CHEN ; JYH-MING LIOU ; YI-CHIA LEE ; TZU-CHAN HONG ; El-Omar E.M.; MING-SHIANG WU | Gut Microbes | 69 | 42 | |
4 | 2020 | Characterization of TMAO productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery | WEI-KAI WU ; Panyod, Suraphan; Liu, Po-Yu; CHIEH-CHANG CHEN ; HSIEN-LI KAO ; Chuang, Hsiao-Li; YING-HSIEN CHEN ; Zou, Hsin-Bai; Kuo, Han-Chun; CHING-HUA KUO ; Liao, Ben-Yang; Chiu, Tina H T; Chung, Ching-Hu; ANGELA YU-CHEN LIN ; YI-CHIA LEE ; Tang, Sen-Lin; JIN-TOWN WANG ; Wu, Yu-Wei; CHENG-CHIH HSU ; LEE-YAN SHEEN ; Orekhov, Alexander N; MING-SHIANG WU | Microbiome | 30 | 26 | |
5 | 2020 | Screening and eradication of Helicobacter pylori for gastric cancer prevention: The Taipei global consensus | JYH-MING LIOU ; Malfertheiner P.; YI-CHIA LEE ; Sheu B.-S.; Sugano K.; Cheng H.-C.; Yeoh K.-G.; Hsu P.-I.; Goh K.-L.; Mahachai V.; Gotoda T.; Chang W.-L.; MEI-JYH CHEN ; TSUNG-HSIEN CHIANG ; CHIEH-CHANG CHEN ; Wu C.-Y.; Leow A.H.-R.; Wu J.-Y.; Wu D.-C.; TZU-CHAN HONG ; Lu H.; Yamaoka Y.; Megraud F.; Chan F.K.L.; Sung J.J.Y.; Lin J.-T.; Graham D.Y.; MING-SHIANG WU ; El-Omar E.M. | Gut | 214 | 187 | |
6 | 2020 | Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial | CHIEH-CHANG CHEN ; Luo J.-C.; YU-JEN FANG ; Lee J.-Y.; Kuo C.-C.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Bair M.-J.; Chen P.-Y.; Chou C.-K.; Chen C.-Y.; Chang C.-Y.; Hsu Y.-C.; Tseng C.-H.; WEN-FENG HSU ; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; MEI-JYH CHEN ; CHIA-TUNG SHUN ; Liu T.-Y.; YI-CHIA LEE ; Liou§ J.-M.; MING-SHIANG WU ; and for the Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Therapeutic Advances in Gastroenterology | 5 | 6 | |
7 | 2018 | Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection | Liou, Jyh-Ming; Chen, Po-Yueh; Luo, Jiing-Chyuan; Lee, Ji-Yuh; CHIEH-CHANG CHEN ; YU-JEN FANG ; Yang, Tsung-Hua; Chang, Chi-Yang; Bair, Ming-Jong; MEI-JYH CHEN ; Hsu, Yao-Chun; WEN-FENG HSU ; Chang, Chun-Chao; JAW-TOWN LIN ; CHIA-TUNG SHUN ; El-Omar, Emad M.; MING-SHIANG WU ; Liou, Jyh-Ming; YI-CHIA LEE ; Lin, Jaw-Town; Wu, Chun-Ying; Wu, Jeng-Yih; Lin, Chun-Hung; Fang, Yu-Ren; Luo, Jiing-Chyuan; TSU-YAO CHENG ; PING-HUEI TSENG ; HAN-MO CHIU ; Chang, Chun-Chao; Yu, Chien-Chun; Chiu, Min-Chin; YEN-NIEN CHEN ; Hu, Wen-Hao; Chou, Chu-Kuang; Tai, Chi-Ming; Lee, Ching-Tai; Wang, Wen-Lun; Chang, Wen-Shiung; Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Gastroenterology | 61 | 50 | |
8 | 2018 | 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; MEI-JYH CHEN ; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; WEN-FENG HSU ; Hu W.-H.; Tsai M.-H.; Lin J.-T.; CHIA-TUNG SHUN ; Twu G.; YI-CHIA LEE ; Bair M.-J.; MING-SHIANG WU ; Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 18 | 15 | |
9 | 2016 | Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial | JYH-MING LIOU ; YU-JEN FANG ; CHIEH-CHANG CHEN ; Bair, Ming-Jong; Chang, Chi-Yang; YI-CHIA LEE ; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; Tseng, Cheng-Hao; Hsu, Yao-Chun; Lee, Ji-Yuh; Yang, Tsung-Hua; Luo, Jiing-Chyuan; Chang, Chun-Chao; Chen, Chi-Yi; Chen, Po-Yueh; CHIA-TUNG SHUN ; WEN-FENG HSU ; Hu, Wen-Hao; YEN-NIEN CHEN ; Sheu, Bor-Shyang; Lin, Jaw-Town; Wu, Jeng-Yih; El-Omar, Emad M; MING-SHIANG WU | Lancet (London, England) | 120 | 112 | |
10 | 2016 | Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial | JYH-MING LIOU ; Bair M.-J.; CHIEH-CHANG CHEN ; YI-CHIA LEE ; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; Tseng C.-H.; YU-JEN FANG ; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; CHIA-TUNG SHUN ; WEN-FENG HSU ; Hung H.-W.; Lin J.-T.; Chang C.-Y.; MING-SHIANG WU | American Journal of Gastroenterology | 40 | 38 | |
11 | 2016 | Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; Chang C.-Y.; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; YU-JEN FANG ; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; CHIA-TUNG SHUN ; Lin J.-T.; YI-CHIA LEE ; MING-SHIANG WU ; the Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Gut | 62 | 59 | |
12 | 2015 | The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study | JYH-MING LIOU ; Chang C.-Y.; MEI-JYH CHEN ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Wu C.-Y.; Yang T.-H.; Chang C.-C.; HSIU-PO WANG ; Sheu B.-S.; Lin J.-T.; Bair M.-J.; MING-SHIANG WU ; Tai C.-M.; Lee C.-T.; Wang W.-L.; YI-CHIA LEE ; Wang Y.-C.; Taiwan Gastrointestinal Disease; Helicobacter Consortium | PLoS ONE | 65 | 63 | |
13 | 2013 | Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; Chang, Chi-Yang; YU-JEN FANG ; Lee, Ji-Yuh; SHIH-JER HSU ; Luo, Jiing-Chyuan; Chang, Wen-Hsiung; Hsu, Yao-Chun; Tseng, Cheng-Hao; PING-HUEI TSENG ; HSIU-PO WANG ; Yang, Ueng-Cheng; CHIA-TUNG SHUN ; Lin, Jaw-Town; YI-CHIA LEE ; MING-SHIANG WU | LANCET | 219 | 196 | |
14 | 2013 | Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; Chang C.-Y.; MEI-JYH CHEN ; YU-JEN FANG ; Lee J.-Y.; CHIEN-CHUAN CHEN ; SHIH-JER HSU ; Hsu Y.-C.; Tseng C.-H.; PING-HUEI TSENG ; Chang L.; Chang W.-H.; HSIU-PO WANG ; CHIA-TUNG SHUN ; Wu J.-Y.; YI-CHIA LEE ; Lin J.-T.; MING-SHIANG WU ; Lin C.-H.; LU-PING CHOW ; TSU-YAO CHENG ; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; CHIH-HSIEN WANG ; Kuo S.-H.; Wu C.-Y. | Journal of Antimicrobial Chemotherapy | 76 | 73 | |
15 | 2012 | Computer-generated surface and tone enhancements to distinguish neoplastic from non-neoplastic colon polyps less than 1 cm in diameter | MING-LUN HAN ; YI-CHIA LEE ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Lee J.-Y.; Lin T.-L.; Lin L.-W.; PING-HUEI TSENG ; MING-SHIANG WU ; HSIU-PO WANG | International Journal of Colorectal Disease | 4 | 3 |